Skip to content

Glytec, LLC (Formally Known AS Glucotec, Inc.)

Country not established

Devices
1

What Glytec, LLC (Formally Known AS Glucotec, Inc.) makes

Glytec, LLC manufactures the G+ System, an intravenous insulin infusion device designed for automated glucose management in hospitalized patients, including those with diabetes or metabolic disorders requiring precise insulin dosing.

The G+ System is classified as a Class II medical device in the U.S. and is listed under FDA’s 510(k) clearance process. The company is headquartered in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • G+ System Ref K101344

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Glytec, LLC (Formally Known AS Glucotec, Inc.) have in the registry?

The registry currently lists 1 device for Glytec, LLC (Formally Known AS Glucotec, Inc.). Devices recorded under merged duplicate company entries are counted once.

Which registries list Glytec, LLC (Formally Known AS Glucotec, Inc.)'s devices?

Among its 1 most recently registered device, Glytec, LLC (Formally Known AS Glucotec, Inc.) has devices listed in FDA 510(k) (1 device).

What risk classes do Glytec, LLC (Formally Known AS Glucotec, Inc.)'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Glytec, LLC (Formally Known AS Glucotec, Inc.)'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Glytec, LLC (Formally Known AS Glucotec, Inc.) in the registry?

The most recently registered devices listed for Glytec, LLC (Formally Known AS Glucotec, Inc.) include G+ SYSTEM.

Generated automatically from registry data and not verified by a human reviewer.